NILA News
2022
5/23/2022
NILA is one of nine parties to new CDC Memorandum of Understanding
5/23/2033
NILA Comments on Discussion Draft of VALID Act released May 17, 2022
3/17/2022
HRSA Program for COVID-19 Testing for the Uninsured
3/4/2022
Announcing the 2022 NILA Lab Leaders Forum and Mid-Year Meeting
2/24/2022
FDA Update - Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers
2/4/2022
NILA Submits Comments on the PREVENT Pandemics Act Discussion Draft
2021
12/7/2021
Congress Reaches Deal to Delay PAMA Cuts, Data Reporting
12/2/2021
Two Court Injunctions Halt CMS Vaccine Mandate for Healthcare Workers Nationwide
11/30/2021
NILA, Partners ask Congress to Stop Harmful Payment Cuts to Clinical Laboratories
10/29/2021
Lab Advisory: CDC Updates Blood Lead Reference Value
9/20/2021
PAMA Recommendations Delivered to Capitol Hill
8/23/2021
NILA Comments on the VALID Act of 2021 (H.R.4128/S.2209)
7/16/2021
NILA Comments on Lab Provisions in Draft of CURES Act 2.0
6/24/2021
NILA Statement on the VALID Act
6/11/2021
NILA Writes Letter to Secretary Becerra Regarding Federal Oversight of LDTs
5/14/2021
NILA Letter to MedPAC Regarding PAMA Fee Schedule Calculations
4/29/2021
NILA, AAB and Partners Request $60M for Advanced Molecular Detection (AMD) Program
1/15/2021
NILA Supports President-Elect Biden’s Plans to Expand and Improve COVID-19 Testing Supplies
Archived News
Click here to see NILA's archived news.